1. New Perspectives in AF and PCI: Implications for the Practicing Physician

3. Program Goals

4. Overview

5. WOEST Study Design

6. WOEST Bleeding and Thrombotic Events

7. PIONEER AF-PCI Study Design

8. PIONEER AF-PCI Clinically Significant Bleeding

9. PIONEER AF-PCI MACE

10. PIONEER AF-PCI Post Hoc Analysis Recurrent Hospitalization

11. RE-DUAL PCI Trial Design

12. RE-DUAL PCI ISTH Major or CRNM Bleeding

13. RE-DUAL PCI: Thromboembolic Events, Death, or Unplanned Revascularization

14. RE-DUAL PCI TIMI Major Bleeding and ICH

15. Triple vs Dual Therapy in AF and PCI: Meta-Analysis

16. Triple Therapy May Still Be Needed in Some Patients

17. AUGUSTUS Study Design

18. ENTRUST-AF PCI Study Design

19. NOAC Dose

20. RENAL-AF Study Design

21. Individualization of Therapy

22. Summary

23. Abbreviations

24. Abbreviations (cont)

25. Abbreviations (cont)

26. Abbreviations (cont)